Prostate-specific antigen (PSA) related to the anthropometric profile among patients admitted at the Hospital II Huamanga Carlos Tuppia García-Godos, EsSalud. Ayacucho

Descripción del Articulo

Objective: To determine the association between plasma and mass prostate-specific antigen (PSA) levels and the anthropometric profile, taking into account the risk of prostate pathologies. Materials and methods: A correlational, quantitative, cross-sectional and retrospective study conducted with a...

Descripción completa

Detalles Bibliográficos
Autores: Gavilán Zamora, Cinthia, Ramírez Roca, Emilio Germán, Castilla-Torres, Nancy Victoria
Formato: artículo
Fecha de Publicación:2021
Institución:Universidad de San Martín de Porres
Repositorio:Horizonte médico
Lenguaje:español
OAI Identifier:oai:horizontemedico.usmp.edu.pe:article/1368
Enlace del recurso:https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/1368
Nivel de acceso:acceso abierto
Materia:Antígeno prostático específico (PSA)
Antropometría
Índice de masa corporal (IMC)
Prostate-specific antigen (PSA)
Anthropometry
Body mass index (BMI)
id REVHM_cae95dbe6acb9167e046d6ef2fc17e69
oai_identifier_str oai:horizontemedico.usmp.edu.pe:article/1368
network_acronym_str REVHM
network_name_str Horizonte médico
repository_id_str
dc.title.none.fl_str_mv Prostate-specific antigen (PSA) related to the anthropometric profile among patients admitted at the Hospital II Huamanga Carlos Tuppia García-Godos, EsSalud. Ayacucho
Antígeno prostático específico (PSA) relacionado al perfil antropométrico en pacientes del Hospital II Huamanga Carlos Tuppia García-Godos, EsSalud. Ayacucho
title Prostate-specific antigen (PSA) related to the anthropometric profile among patients admitted at the Hospital II Huamanga Carlos Tuppia García-Godos, EsSalud. Ayacucho
spellingShingle Prostate-specific antigen (PSA) related to the anthropometric profile among patients admitted at the Hospital II Huamanga Carlos Tuppia García-Godos, EsSalud. Ayacucho
Gavilán Zamora, Cinthia
Antígeno prostático específico (PSA)
Antropometría
Índice de masa corporal (IMC)
Prostate-specific antigen (PSA)
Anthropometry
Body mass index (BMI)
title_short Prostate-specific antigen (PSA) related to the anthropometric profile among patients admitted at the Hospital II Huamanga Carlos Tuppia García-Godos, EsSalud. Ayacucho
title_full Prostate-specific antigen (PSA) related to the anthropometric profile among patients admitted at the Hospital II Huamanga Carlos Tuppia García-Godos, EsSalud. Ayacucho
title_fullStr Prostate-specific antigen (PSA) related to the anthropometric profile among patients admitted at the Hospital II Huamanga Carlos Tuppia García-Godos, EsSalud. Ayacucho
title_full_unstemmed Prostate-specific antigen (PSA) related to the anthropometric profile among patients admitted at the Hospital II Huamanga Carlos Tuppia García-Godos, EsSalud. Ayacucho
title_sort Prostate-specific antigen (PSA) related to the anthropometric profile among patients admitted at the Hospital II Huamanga Carlos Tuppia García-Godos, EsSalud. Ayacucho
dc.creator.none.fl_str_mv Gavilán Zamora, Cinthia
Ramírez Roca, Emilio Germán
Castilla-Torres, Nancy Victoria
author Gavilán Zamora, Cinthia
author_facet Gavilán Zamora, Cinthia
Ramírez Roca, Emilio Germán
Castilla-Torres, Nancy Victoria
author_role author
author2 Ramírez Roca, Emilio Germán
Castilla-Torres, Nancy Victoria
author2_role author
author
dc.subject.none.fl_str_mv Antígeno prostático específico (PSA)
Antropometría
Índice de masa corporal (IMC)
Prostate-specific antigen (PSA)
Anthropometry
Body mass index (BMI)
topic Antígeno prostático específico (PSA)
Antropometría
Índice de masa corporal (IMC)
Prostate-specific antigen (PSA)
Anthropometry
Body mass index (BMI)
description Objective: To determine the association between plasma and mass prostate-specific antigen (PSA) levels and the anthropometric profile, taking into account the risk of prostate pathologies. Materials and methods: A correlational, quantitative, cross-sectional and retrospective study conducted with a sample of 156 medical records of male patients with PSA tests and anthropometric data. Spearman's Rho with a 95 % confidence level was used to analyze the relationship between the variables. Results: The average age of the patients was 67.85 ± 10.83 years and their mean PSA value was 3.57 ± 7.30 ng/mL. Fifteen (15) patients (9.60 %) had a low risk (PSA = 4.1 – 9.90 ng/mL), eight (5.10 %) a medium risk (PSA = 10 – 19.90 ng/mL) and six (3.80 %) a high risk (PSA ≥ 20 ng/mL) of developing prostate pathologies. The mean body mass index (BMI) was 26.37 ± 3.81 kg/m2: 85 patients (54.50 %) were overweight and 18 (11.50 %) were obese. The mean mass PSA was 14.89 ± 30.50 μg, the body surface area (BSA) was 3.93 ± 2.72 m2 and the plasma volume was 4.18 ± 0.21 L. A very low positive correlation was evidenced between plasma PSA and age (rho = 0.184; p = 0.022) and between mass PSA and age (rho = 0.176; p = 0.028). There was a moderate positive association between plasma PSA and BSA (rho = 0.456; p = 0.000) and between mass PSA and BSA (rho = 0.463; p = 0.000). No relationship was found between BMI and PSA. Conclusions: The association between plasma and mass PSA levels and the anthropometric profile was demonstrated, taking into account the risk of prostate pathologies, which increased with BSA and age.
publishDate 2021
dc.date.none.fl_str_mv 2021-07-01
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/1368
10.24265/horizmed.2021.v21n3.07
url https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/1368
identifier_str_mv 10.24265/horizmed.2021.v21n3.07
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/1368/939
https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/1368/1028
https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/1368/1008
dc.rights.none.fl_str_mv Derechos de autor 2021 Horizonte Médico (Lima)
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Derechos de autor 2021 Horizonte Médico (Lima)
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
text/html
text/xml
dc.publisher.none.fl_str_mv Universidad de San Martín de Porres. Facultad de Medicina Humana
publisher.none.fl_str_mv Universidad de San Martín de Porres. Facultad de Medicina Humana
dc.source.none.fl_str_mv Horizonte Médico (Lima); Vol. 21 No. 3 (2021): July - September; e1368
Horizonte Médico (Lima); Vol. 21 Núm. 3 (2021): Julio - Setiembre; e1368
Horizonte Médico (Lima); v. 21 n. 3 (2021): Julio - Setiembre; e1368
2227-3530
1727-558X
reponame:Horizonte médico
instname:Universidad de San Martín de Porres
instacron:USMP
instname_str Universidad de San Martín de Porres
instacron_str USMP
institution USMP
reponame_str Horizonte médico
collection Horizonte médico
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1843452313287524352
spelling Prostate-specific antigen (PSA) related to the anthropometric profile among patients admitted at the Hospital II Huamanga Carlos Tuppia García-Godos, EsSalud. AyacuchoAntígeno prostático específico (PSA) relacionado al perfil antropométrico en pacientes del Hospital II Huamanga Carlos Tuppia García-Godos, EsSalud. AyacuchoGavilán Zamora, Cinthia Ramírez Roca, Emilio Germán Castilla-Torres, Nancy Victoria Antígeno prostático específico (PSA)AntropometríaÍndice de masa corporal (IMC) Prostate-specific antigen (PSA)AnthropometryBody mass index (BMI) Objective: To determine the association between plasma and mass prostate-specific antigen (PSA) levels and the anthropometric profile, taking into account the risk of prostate pathologies. Materials and methods: A correlational, quantitative, cross-sectional and retrospective study conducted with a sample of 156 medical records of male patients with PSA tests and anthropometric data. Spearman's Rho with a 95 % confidence level was used to analyze the relationship between the variables. Results: The average age of the patients was 67.85 ± 10.83 years and their mean PSA value was 3.57 ± 7.30 ng/mL. Fifteen (15) patients (9.60 %) had a low risk (PSA = 4.1 – 9.90 ng/mL), eight (5.10 %) a medium risk (PSA = 10 – 19.90 ng/mL) and six (3.80 %) a high risk (PSA ≥ 20 ng/mL) of developing prostate pathologies. The mean body mass index (BMI) was 26.37 ± 3.81 kg/m2: 85 patients (54.50 %) were overweight and 18 (11.50 %) were obese. The mean mass PSA was 14.89 ± 30.50 μg, the body surface area (BSA) was 3.93 ± 2.72 m2 and the plasma volume was 4.18 ± 0.21 L. A very low positive correlation was evidenced between plasma PSA and age (rho = 0.184; p = 0.022) and between mass PSA and age (rho = 0.176; p = 0.028). There was a moderate positive association between plasma PSA and BSA (rho = 0.456; p = 0.000) and between mass PSA and BSA (rho = 0.463; p = 0.000). No relationship was found between BMI and PSA. Conclusions: The association between plasma and mass PSA levels and the anthropometric profile was demonstrated, taking into account the risk of prostate pathologies, which increased with BSA and age.Objetivo: Determinar la asociación del nivel de antígeno prostático específico (PSA) plasmático y PSA masa según riesgo de padecer enfermedades prostáticas con el perfil antropométrico. Materiales y métodos: Estudio correlacional, de enfoque cuantitativo de dimensión transversal y retrospectiva. La muestra estuvo constituida por 156 historias clínicas de pacientes varones, con pruebas de PSA y datos antropométricos. Para el análisis de la relación de las variables se utilizó la prueba Rho de Spearman, con un nivel de confianza de 95 %. Resultados: La edad promedio de los pacientes fue 67,85±10,83 años y presentaron un valor medio de PSA de 3,57±7,30 ng/mL. El 9,60 % (15 pacientes) tuvo un riesgo bajo de padecer enfermedades prostáticas (PSA = 4,1-9,90 ng/mL); el 5,10 % (8 individuos) mostró riesgo intermedio (PSA= 10-19,90 ng/mL); y el 3, 80 %(6 pacientes) tuvo un riesgo alto (PSA ≥20 ng/mL). El promedio del índice de masa corporal (IMC) fue 26,37±3,81 kg/m2 : 85 pacientes (54,50 %) tenían sobrepeso; y 18 (11,50 %), obesidad. La media de PSA masa fue14,89±30,50 μg; la superficie corporal (SC) se calculó en 3,93± 2,72 m2; y el volumen plasmático fue 4,18± 0,21 L. Se evidenció una correlación positiva muy baja entre el PSA plasmático y la edad (rho = 0,184; p = 0,022), así como con entre la PSA masa y la edad (rho = 0,176; p = 0,028). Se obtuvo una asociación positiva moderada entre el PSA plasmático y la superficie corporal (SC) (rho = 0,456; p = 0,000); y entre el PSA masa y SC (rho = 0,463; p = 0,000). No se encontró relación entre el IMC y el PSA. Conclusiones: Se evidenció la asociación entre el valor de PSA plasmático y PSA masa con el perfil antropométrico, según el riesgo de padecer enfermedades prostáticas, que fue mayor con la superficie corporal y la edad.Universidad de San Martín de Porres. Facultad de Medicina Humana2021-07-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdftext/htmltext/xmlhttps://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/136810.24265/horizmed.2021.v21n3.07Horizonte Médico (Lima); Vol. 21 No. 3 (2021): July - September; e1368Horizonte Médico (Lima); Vol. 21 Núm. 3 (2021): Julio - Setiembre; e1368Horizonte Médico (Lima); v. 21 n. 3 (2021): Julio - Setiembre; e13682227-35301727-558Xreponame:Horizonte médicoinstname:Universidad de San Martín de Porresinstacron:USMPspahttps://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/1368/939https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/1368/1028https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/1368/1008Derechos de autor 2021 Horizonte Médico (Lima)https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessoai:horizontemedico.usmp.edu.pe:article/13682022-06-22T17:15:31Z
score 13.461011
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).